These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28652746)

  • 21. Lack of Association between the Serotonin Transporter (5-HTT) and Serotonin Receptor (5-HT2A) Gene Polymorphisms with Smoking Behavior among Malaysian Malays.
    Rozak NI; Ahmad I; Gan SH; Abu Bakar R
    Sci Pharm; 2014; 82(3):631-42. PubMed ID: 25853073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The psychometric validity of the Montgomery-Åsberg Depression Rating Scale (MADRS) in recent onset schizophrenia spectrum disorders.
    Herniman SE; Cotton SM; Allott KA; Phillips LJ; Wood SJ;
    Schizophr Res; 2021 Feb; 228():373-381. PubMed ID: 33548838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression.
    Higuchi H; Takahashi H; Kamata M; Yoshida K
    Neuropsychiatr Dis Treat; 2009; 5():393-8. PubMed ID: 19649213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.
    Robinson DS; Gilmor ML; Yang Y; Moonsammy G; Azzaro AJ; Oren DA; Campbell BJ
    Psychopharmacol Bull; 2007; 40(3):15-28. PubMed ID: 18007565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.
    Kishida I; Aklillu E; Kawanishi C; Bertilsson L; Agren H
    Neuropsychopharmacology; 2007 Oct; 32(10):2143-51. PubMed ID: 17299512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor analysis of the Montgomery Asberg Depression Rating Scale in 251 bipolar II and 306 unipolar depressed outpatients.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Oct; 25(7):1369-76. PubMed ID: 11513352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis.
    Mak KK; Kong WY; Mak A; Sharma VK; Ho RC
    J Neurol Neurosurg Psychiatry; 2013 Mar; 84(3):322-8. PubMed ID: 23236014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males.
    Chu SL; Xiao D; Wang C; Jing H
    Chin Med J (Engl); 2009 Jun; 122(12):1365-8. PubMed ID: 19567154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
    Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of serotonin transporter gene-linked polymorphic region and variable number of tandem repeat polymorphism of the serotonin transporter gene in lichen simplex chronicus patients with psychiatric status.
    Kirtak N; Inaloz HS; Akçali C; Erdal E; Herken H; Yildirim M; Erguven HG
    Int J Dermatol; 2008 Oct; 47(10):1069-72. PubMed ID: 18986359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The course of depression in late life as measured by the Montgomery and Asberg Depression Rating Scale in an observational study of hospitalized patients.
    Borza T; Engedal K; Bergh S; Benth JŠ; Selbæk G
    BMC Psychiatry; 2015 Aug; 15():191. PubMed ID: 26242794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg Depression Rating Scale for treatment-resistant depressed patients.
    Okazaki M; Tominaga K; Higuchi H; Utagawa I; Nakamura E; Noguchi M; Itaya M; Hashimoto C; Yamaguchi N
    J ECT; 2010 Jun; 26(2):87-90. PubMed ID: 19710622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazole.
    Reimherr FW; Martin ML; Eudicone JM; Marchant BK; Tran QV; Pikalov A; Marcus RN; Berman RM; Carlson BX
    J Clin Psychopharmacol; 2010 Jun; 30(3):300-5. PubMed ID: 20473067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The assessment of depression in Parkinson's disease.
    Koerts J; Leenders KL; Koning M; Bouma A; van Beilen M
    Eur J Neurol; 2008 May; 15(5):487-92. PubMed ID: 18355310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serotonin transporter gene polymorphisms in irritable bowel syndrome and their impact on tegaserod treatment].
    Li YY; Nie YQ; Xie J; Tan HZ; Zhou YJ; Wang H
    Zhonghua Nei Ke Za Zhi; 2006 Jul; 45(7):552-5. PubMed ID: 17074108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism.
    Lonsdorf TB; Rück C; Bergström J; Andersson G; Ohman A; Schalling M; Lindefors N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1479-83. PubMed ID: 19683026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific depressive symptoms predict remission to aripiprazole augmentation in late-life treatment resistant depression.
    Gebara MA; DiNapoli EA; Kasckow J; Karp JF; Blumberger DM; Lenze EJ; Mulsant BH; Reynolds CF
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):e330-e335. PubMed ID: 28975710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Changes in Poststroke Depressive Symptoms: Effects of Functional Disability and Social Support.
    Ryu JC; Kim JS;
    J Neuropsychiatry Clin Neurosci; 2023; 35(3):244-249. PubMed ID: 36999251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Tran P; Skolnick P; Czobor P; Huang NY; Bradshaw M; McKinney A; Fava M
    J Psychiatr Res; 2012 Jan; 46(1):64-71. PubMed ID: 21925682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Residual symptoms in older patients treated for major depression.
    Hybels CF; Steffens DC; McQuoid DR; Rama Krishnan KR
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1196-202. PubMed ID: 16315146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.